The pathophysiology of agitation

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 14, 2000, Pages 5-10

  Lindenmayer, J P ^a  

^a MANHATTAN PSYCHIATRIC CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; ARTICLE; BEHAVIOR; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; HUMAN; IRRITABILITY; MENTAL DISEASE; MOTOR ACTIVITY; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SLEEP DISORDER; STIMULUS RESPONSE; TREATMENT PLANNING;

AGGRESSION; BEHAVIORAL SYMPTOMS; BIPOLAR DISORDER; DEMENTIA; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MENTAL DISORDERS; NOREPINEPHRINE; PSYCHOMOTOR AGITATION; PSYCHOSES, SUBSTANCE-INDUCED; SEROTONIN; VIOLENCE;

EID: 0034500776     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Restlessness: The anatomy of a neuropsychiatric symptom
2. Agitated behaviors in the elderly: A conceptual review
3. The overt agitation severity scale for the objective rating of agitation
4. The overt aggression scale for objective rating of verbal and physical aggression
5. The motor agitation and Retardation Scale: A scale for the assessment of motor abnormalities in depressed patients
6. Assessing patterns of agitation in patients with Alzheimer's disease with the CMAl
7. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, ocularmator, "prefrontal" and "limbic" functions
8. Disinhibition as a basic process in the expression of striatal functions
9. DA receptors in the basal ganglia: Relevance to Parkinson's disease
10. Neurotransmitters and neuromodulators in the basal ganglia
11. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
12. Neurotransmitters and CNS disease
13. Noradrenergic mechanisms in Parkinson's disease
14. Mixed depression and anxiety: Serotonin-1A receptors as a common pharmacologic link
15. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia, agitation
16. Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders
17. Anger and anxiety responses to m-CPP in GAD
18. Specificity of mixed affective states: Clinical comparison of mixed mania and agitated depression
19. Central serotonin activity and aggression
20. Serotonergic studies with patients with affective and personality disorders: Correlates with suicidal and impulsive behaviors
21. Treatment of agitation in dementia
22. Effects of Alzheimer's disease and normal aging on CSF NE responses to yohimbine and clonidine
23. Biological basis of generalized anxiety disorder
24. A disorder of cortical GABAergic innervation in Alzheimer's disease
25. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: Toward a treatment approach
26. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid in patients with senile dementia of Alzheimer type
27. Valproic acid treatment of agitation in dementia
28. Phenomenology and treatment of agitation
29. The behavioral effect of m-CPP and methylphenidate in first episode schizophrenia and normal controls
30. Interactions between the glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
31. 2 receptor effects of antipsychotics: Bridging basic and clinical findings using PET
32. 5HT and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
33. Selective D1 and D2 dopamine receptor blockade both induces akathisia in humans
34. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin